Bruker Corporation (BRKR)
NASDAQ: BRKR · IEX Real-Time Price · USD
81.48
+0.89 (1.10%)
Apr 26, 2024, 10:45 AM EDT - Market open

Bruker Revenue

In the year 2023, Bruker had annual revenue of $2.96B with 17.14% growth. Revenue in the quarter ending December 31, 2023 was $854.50M with 20.62% year-over-year growth.

Revenue (ttm)
$2.96B
Revenue Growth
+17.14%
P/S Ratio
3.74
Revenue / Employee
$305,398
Employees
9,707
Market Cap
11.28B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.96B433.80M17.14%
Dec 31, 20222.53B112.80M4.67%
Dec 31, 20212.42B430.40M21.66%
Dec 31, 20201.99B-85.10M-4.11%
Dec 31, 20192.07B177.00M9.34%
Dec 31, 20181.90B129.70M7.34%
Dec 31, 20171.77B154.60M9.59%
Dec 31, 20161.61B-12.50M-0.77%
Dec 31, 20151.62B-185.10M-10.23%
Dec 31, 20141.81B-30.50M-1.66%
Dec 31, 20131.84B48.00M2.68%
Dec 31, 20121.79B139.70M8.46%
Dec 31, 20111.65B346.80M26.58%
Dec 31, 20101.30B190.40M17.08%
Dec 31, 20091.11B7.40M0.67%
Dec 31, 20081.11B74.70M7.24%
Dec 31, 20071.03B181.00M21.26%
Dec 31, 2006851.40M479.15M128.72%
Dec 31, 2005372.25M15.26M4.28%
Dec 31, 2004356.99M96.31M36.95%
Dec 31, 2003260.68M40.02M18.14%
Dec 31, 2002220.66M45.38M25.89%
Dec 31, 2001175.28M98.68M128.82%
Dec 31, 200076.60M11.91M18.41%
Dec 31, 199964.69M22.48M53.27%
Dec 31, 199842.21M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DaVita 12.14B
Solventum 8.20B
Smith & Nephew 5.55B
Charles River Laboratories International 4.13B
Catalent 4.10B
Incyte 3.70B
Exact Sciences 2.50B
United Therapeutics 2.33B
Revenue Rankings